Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SOLAZYME Inc SZYM

"Solazyme Inc, along with its subsidiaries, is engaged in providing renewable oils and other bioproducts. It commercializes its products into target markets such as chemicals and fuels, nutrition, and skin and personal care."


NDAQ:SZYM - Post by User

<< Previous
Bullboard Posts
Post by taliuson Mar 21, 2014 7:38pm
453 Views
Post# 22354538

Bullish rec by broker today to me on SZYM

Bullish rec by broker today to me on SZYMBroker told me he has a price target of $32 and could take 3 years to play out to that point. Said demand is not an issue for the company for the next few years as it makes great products, and there's an established market for them. Rather, the ability to produce enough products will be the company's main constraint for the next several years. In 2013, SZYM, in a joint venture with ADM, completed a facility in Clinton, IA. In March or April of this year, the company is scheduled to begin production in a facility in Brazil that was constructed through a joint venture with Bunge. These facilities will be producing products that address a market of a least $11.7 billion. SZYM plans to ramp these two facilities to output of 120 metric tons (MT) in 12 to 18 months. At an average bulk selling price for the outputs of $2,600/MT, that level of production would equate to $312 million in revenue. As they scale up, the plants have a combined capacity of 400 MT; by 2016 I expect the company will have ramped to about 60% of its capacity, or 240 MT. That would amount to $624 million. Allowing for growth of the $40 million in sales of products that are currently being produced by the company's contract manufacturers, I foresee 2016 revenues of about $700 million, far more than enough to make the company healthily profitable. On that revenue, I estimate 2016 earnings per share of $1.03.
<< Previous
Bullboard Posts